Paclitaxel/ramucirumabAnorexia and hypertension: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1834卷 / 1期

关键词：

D O I：

10.1007/s40278-020-87406-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：214 / 214

相关论文

共 50 条

[21] EverolimusAnaemia and hypertension: 2 case reports
Reactions Weekly, 2017, 1667 (1) : 146 - 146
[22] BevacizumabArterial hypertension: 2 case reports
Reactions Weekly, 2009, 1278 (1) : 11 - 11
[23] DexamethasoneOcular hypertension: 2 case reports
Reactions Weekly, 2022, 1894 (1) : 131 - 131
[24] RivoceranibDiarrhoea and hypertension: 2 case reports
Reactions Weekly, 2022, 1908 (1) : 497 - 497
[25] Carboplatin/paclitaxel/vinorelbineLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1923 (1) : 128 - 128
[26] Carboplatin/Paclitaxel/TrastuzumabVarious toxicities: 2 case reports
Reactions Weekly, 2024, 2029 (1) : 148 - 148
[27] Cisplatin/paclitaxel/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2024, 2024 (1) : 140 - 140
[28] Paclitaxel/ramucirumabThrombocytopenia and gastric perforation: 2 case reports
Reactions Weekly, 2019, 1771 (1) : 239 - 239
[29] Paclitaxel/pembrolizumabRadiation recall pneumonitis: 2 case reports
Reactions Weekly, 2022, 1936 (1) : 399 - 399
[30] Paclitaxel/sirolimusLate stent thrombosis: 2 case reports
Reactions Weekly, 2006, 1116 (1) : 21 - 21

← 1 2 3 4 5 →